RBF Capital, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 23 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RBF Capital, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,384,000
+10546.2%
235,000
+840.0%
0.08%
+7500.0%
Q2 2020$13,000
-31.6%
25,0000.0%0.00%
-50.0%
Q4 2019$19,000
-29.6%
25,0000.0%0.00%
-33.3%
Q3 2019$27,000
+50.0%
25,0000.0%0.00%
+50.0%
Q2 2019$18,000
-43.8%
25,0000.0%0.00%
-50.0%
Q1 2019$32,000
-15.8%
25,0000.0%0.00%
-20.0%
Q4 2018$38,000
+5.6%
25,0000.0%0.01%
+25.0%
Q3 2018$36,000
+2.9%
25,0000.0%0.00%0.0%
Q2 2018$35,00025,0000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders